Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.46 |
| ▸ | FAAH | O00519 | 6/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14049054 | 0.90 | ALDH1A1 (0.48) | NOD1FAAHALDH1A1MEN1MAPK1 | |
| SCHEMBL10088106 | 0.90 | FAAH (0.36) | NOD1FAAHALDH1A1KMT2APLA2G10 | |
| SCHEMBL10359007 | 0.88 | FAAH (0.53) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL10088129 | 0.87 | FAAH (0.50) | NOD1FAAHALDH1A1MEN1MAPK1 | |
| SCHEMBL15268251 | 0.86 | FAAH (0.52) | NOD1FAAHALDH1A1MEN1MAPK1 | |
| SCHEMBL10088128 | 0.84 | CASP2 (0.53) | NOD1FAAHALDH1A1EPHX2SMN1; SMN2 | |
| SCHEMBL10088089 | 0.76 | FAAH (0.38) | NOD1FAAHALDH1A1MEN1MAPK1 | |
| SCHEMBL21686226 | 0.75 | FAAH (0.59) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL14854452 | 0.74 | FAAH (0.53) | NOD1FAAHMEN1MAPK1KMT2A | |
| SCHEMBL9828757 | 0.74 | FAAH (0.61) | NOD1FAAHALDH1A1MEN1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8092782-B2 | Polybiotin compounds of magnetic resonance imaging and drug delivery | THE GENERAL HOSPITAL CORPORATION (US) | 2012-01-10 | — | — | US | disclosed |
| US-20090010845-A1 | Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery | THE GENERAL HOSPITAL CORPORATION (US) | 2009-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090010845-A1 | Polybiotin Compounds of Magnetic Resonance Imaging and Drug Delivery | BTD, BCAT1, BRD4 | NOD1 101/4885FAAH 3209/4885ALDH1A1 4091/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.